BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6266635)

  • 1. The characteristics of long-term survivors of lung cancer treated with radiation.
    Sherman DM; Weichselbaum R; Hellman S
    Cancer; 1981 Jun; 47(11):2575-80. PubMed ID: 6266635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresectable non-oat cell carcinoma of the lung: definitive radiation therapy.
    Mantravadi RV; Gates JO; Crawford JN; Bajpai D; Trenkner JD; Jordan LN
    Radiology; 1989 Sep; 172(3):851-5. PubMed ID: 2549566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience.
    Madej PJ; Bitran JD; Golomb HM; Hoffman PG; DeMeester T; Desser RK; Kaul R; Raghavan V; Newman SB; Skosey C
    Cancer; 1984 Jul; 54(1):5-12. PubMed ID: 6326999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-a-week irradiation for locally advanced lung cancer.
    Salazar OM; Van Houtte P; Rubin P
    Int J Radiat Oncol Biol Phys; 1983 Jun; 9(6):923-30. PubMed ID: 6305892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
    Cicenas S; Zaliene A; Atkocius V
    Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
    Westover KD; Loo BW; Gerber DE; Iyengar P; Choy H; Diehn M; Hughes R; Schiller J; Dowell J; Wardak Z; Sher D; Christie A; Xie XJ; Corona I; Sharma A; Wadsworth ME; Timmerman R
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):72-81. PubMed ID: 26279026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.
    Garg S; Gielda BT; Kiel K; Turian JV; Fidler MJ; Batus M; Bonomi P; Sher DJ
    Pract Radiat Oncol; 2014; 4(5):342-348. PubMed ID: 25194104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach.
    Choi NC; Doucette JA
    Cancer; 1981 Jul; 48(1):101-9. PubMed ID: 6263449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
    Spásová I; Petera J
    Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
    Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
    J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
    Cox JD; Samson MK; Herskovic AM; Abrams R; Koehler M
    Cancer Treat Rep; 1986 Oct; 70(10):1219-20. PubMed ID: 3019546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
    Hasselle MD; Haraf DJ; Rusthoven KE; Golden DW; Salgia R; Villaflor VM; Shah N; Hoffman PC; Chmura SJ; Connell PP; Vokes EE; Weichselbaum RR; Salama JK
    J Thorac Oncol; 2012 Feb; 7(2):376-81. PubMed ID: 22198429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical radiation therapy of advanced lung cancer: evaluation of prognostic factors and results of continuous and split course treatment.
    Emami B; Munzenrider JE; Lee DJ; Rene JB
    Cancer; 1979 Aug; 44(2):446-56. PubMed ID: 224998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older.
    Furuta M; Hayakawa K; Katano S; Saito Y; Nakayama Y; Takahashi T; Imai R; Ebara T; Mitsuhashi N; Niibe H
    Jpn J Clin Oncol; 1996 Apr; 26(2):95-8. PubMed ID: 8609701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of single brain metastasis from non-oat cell lung carcinoma. Surgery and radiation versus radiation therapy alone.
    Mandell L; Hilaris B; Sullivan M; Sundaresan N; Nori D; Kim JH; Martini N; Fuks Z
    Cancer; 1986 Aug; 58(3):641-9. PubMed ID: 3731022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of postoperative irradiation for stage III lung cancer.
    Nishikawa K; Koga K; Shibata K; Wake N; Takeuchi M; Watanabe K
    Radiat Med; 1984; 2(2):143-7. PubMed ID: 6097948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.